This award is in recognition of Bruker Daltonics's contributions to a broad array of mass spectrometry technologies and for its commitment to the growing field of proteomics
Bruker Daltonics has been selected for the Frost and Sullivan 2005 Product Innovation Award.
This award is in recognition of Bruker Daltonics's contributions to a broad array of mass spectrometry technologies and for its commitment to the growing field of proteomics.
"Bruker Daltonics has been highly proactive in leveraging its array of mass spectrometry technologies towards drug discovery and clinical research applications.
"The key competitive and differentiating factor that provides Bruker Daltonics the leading edge is its ability to enhance technology.
"This is done in tandem with realising meaningful life sciences applications through an integrated system solutions approach from the sample preparation phase to the data integration stage in protein identification", said Frost and Sullivan healthcare analyst Charanya Ramachandran.
"The expansion of Bruker Daltonics's ClinProt product portfolio has shown a tremendous promise to move biomarker discovery and future molecular diagnostics to the next dimension.
"Bruker Daltonics has streamlined the proteome workflow with the introduction of bioinformatics tools that will complement the use of ClinProt for effective data analysis", stated Sumit Sharma, director, healthcare research.
"In recognition of this technology giant's core competencies in research and development" Frost and Sullivan president Krishna Srinivasan said he "applauds Bruker Daltonics for its persistent efforts in bringing out a multifaceted product line to further bioresearch and meet customer needs by offering an integrated solution".
Given that Bruker Daltonics continues to exhibit an outstanding dedication to life sciences research, both in-house and through alliances, Frost and Sullivan expects Bruker Daltonics to retain its leading position in mass spectrometry and accelerate proteome research in the future.
Frank Laukien, president and CEO of Bruker Daltonics, commented: "We are quite gratified by this award, and indeed pleased to have been recognised by Frost and Sullivan for the fifth time now in four years for our innovation and growth strategy in the life sciences".
